ProGenis Pharmaceuticals is proud to announce that we have been awarded the 2025 Rio Tinto Emerging Innovation Award at the… Read More »ProGenis Pharmaceuticals Wins the 2025 Rio Tinto Emerging Innovation Award
Singapore — October 15–16, 2025 Professor Marvin H. Caruthers, Co-Founder of ProGenis Pharmaceuticals and world-renowned pioneer in nucleic-acid chemistry, was… Read More »Prof. Marvin H. Caruthers and Prof. Rakesh N. Veedu Represent ProGenis at RNA Leaders APAC 2025
We’re proud to share that Professor Rakesh N. Veedu, Co-Founder and Managing Director of ProGenis Pharmaceuticals, has been invited to… Read More »Prof. Rakesh N. Veedu to Speak at RNA Leaders APAC 2025
We were honoured to participate in the official launch of the Targeted Translation Research Accelerator (TTRA) Drugs & Devices Program… Read More »ProGenis Participates in the Official Launch of the TTRA Drugs & Devices Program
We had such an inspiring time at our Diabetes Consumer Event held at ProGenis Pharmaceuticals on Wednesday, August 20, 2025.… Read More »ProGenis Hosts Inspiring Diabetes Consumer Event Highlighting Breakthrough RNA Therapeutic
We are delighted to announce that ProGenis Pharmaceuticals has been named a finalist in the 2025 WA Innovators of the… Read More »ProGenis Pharmaceuticals Named Finalist in the 2025 WA Innovators of the Year Awards
ProGenis Pharmaceuticals is thrilled to announce that we have been awarded funding from the Medical Research Future Fund (MRFF) under… Read More »ProGenis Pharmaceuticals Awarded MRFF TTRA Funding to Advance RNA Therapeutic for Type 2 Diabetes
ProGenis Pharmaceuticals is excited to announce our sponsorship of the First Nucleic Acid Therapeutics Regional Meeting – India 2025, taking… Read More »ProGenis Pharmaceuticals Proudly Sponsors the First Nucleic Acid Therapeutics Regional Meeting – India 2025
ProGenis Pharmaceuticals is proud to have been one of the sponsors for the incredible Spotlight on 2024 event, celebrating WA’s dynamic #LifeSciences… Read More »Celebrating WA’s Thriving Life Sciences Sector: A Night to Remember
ProGenis Pharmaceuticals marked a significant milestone—its first anniversary—by hosting a memorable event that brought together over 60 distinguished guests from… Read More »Celebrating a Year of Innovation: ProGenis Pharmaceuticals Anniversary Event
ProGenis Pharmaceuticals is proud to welcome Professor Girish Dwivedi as its new Clinical Advisor for Cardiovascular Diseases. A highly respected… Read More »ProGenis Pharmaceuticals Welcomes Professor Girish Dwivedi as Clinical Advisor for Cardiovascular Diseases
The streets of Perth turned vibrant this morning as thousands of participants gathered for the 12th annual HBF Run for a… Read More »ProGenis Pharmaceuticals Runs for a Reason at the Annual 2024 HBF Run: Supporting the Australian Coeliac Association